NCT05941377 - Enhanced Versus Standard Blood Pressure Lowering on Intracranial Aneurysm Rupture or Growth China Antihypertensive Trial for Intracranial Aneurysm (ChATIA-1) | Biotech Hunter

Enrollment

520

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2026

Conditions

Unruptured Intracranial Aneurysm

Interventions

OTHER

blood pressure lowering

For EBPL group, patients are required to keep blood pressure at 100-120 mmHg. For SBPL group, patients are required to keep blood pressure at 120-140 mmHg.

Trial Locations (1)

Unknown

RECRUITING

Capital Medical University Affiliated Beijing Tiantan Hospital, Beijing

All Listed Sponsors

collaborator

RenJi Hospital

OTHER

collaborator

Guangzhou Red Cross Hospital

OTHER

collaborator

Jiangnan University Medical Center

UNKNOWN

collaborator

The First Dongguan Affiliated Hospital of Guangdong Medical University

UNKNOWN

lead

Beijing Tiantan Hospital

OTHER